Martin Puchwein Country President & Head of Business Unit Pharmaceuticals Martin Puchwein joined the Novartis Group in 2010 as part of its generic division Sandoz. Later, he worked among other things, in the Pharmaceuticals division of the German branch of Novartis. Prior to joining Novartis Group, he worked for the Boston Consulting Group and completed his doctoral studies at the Federal Technical University in Zurich (ETH Zürich). LinkedIn
Carolyn Sousa Head of Business Unit Oncology Carolyn began her career at Novartis Group in 2009 as Global Director of Corporate Strategy. She has experience in leading business positions in various therapeutic areas. Prior to coming to the Czech Republic, she led the Immunology & Dermatology franchise in Australia. LinkedIn
Darren Glynn Head NGSC Prague & NBS CONEXTS Region Europe, CZ Novartis Darren Glynn accepted the role of Head of NGSC Prague at the end of 2019, in addition to his current position as NBS CONEXTS Region Europe. He has led diverse teams of customer-focused professionals, leading them to new levels of success, even in the highly competitive environment of global companies with rapidly changing operations. Darren sees great potential at NGCS Prague due to his strategic location and especially due to the diversity of his employees and his primary goal is the further development of this company. LinkedIn
Jiří Hanzlík Country Head Sandoz s.r.o. Jiří joined Sandoz in 2011 and has been in the lead since 2017. He also represents Sandoz in the Czech Association of Pharmaceutical Companies. LinkedIn
Ivo Hlaváč Country Public Affairs Head Since 2018, he has represented Novartis in negotiations with state administration bodies. He is the chairman of the Health and Social Services Section of the Czech Chamber of Commerce. In the past, he held various positions at ČEZ. He also held the role of Deputy Minister of Agriculture of the Czech Republic and Deputy Minister of the Environment of the Czech Republic LinkedIn
